Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic and infectious diseases
3.2.1.2 Advancements in biotechnology
3.2.1.3 Technological progress
3.2.1.4 Government investment in research
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of enzymes
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Gap analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Form, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Powder
5.3 Liquid
Chapter 6 Market Estimates and Forecast, By Therapeutic Area, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Infectious diseases
6.3 Oncology
6.4 Diabetes
6.5 Cardiology
6.6 Other therapeutic areas
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Isolation and purification of genomic DNA & RNA
7.3 In situ hybridization
7.4 Mitochondria isolation
7.5 Other applications
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Biotechnology companies
8.3 Contract research organizations
8.4 Diagnostic laboratories
8.5 Other end users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Abcam
10.2 Agilent Technologies
10.3 Bioline (Meridian Biosciences)
10.4 BIORON
10.5 F. Hoffmann-La Roche
10.6 Merck
10.7 Minerva Biolabs
10.8 MP BIOMEDICALS.
10.9 New England Biolabs
10.10 Norgen Biotek
10.11 Promega Corporation
10.12 QIAGEN
10.13 Sisco Research Laboratories
10.14 Takara Bio
10.15 Thermo Fisher Scientific
